A B S T R A C T Arteriovenous differences (A-V) of all naturally occurring amino acids, lactate, and oxygen were measured simultaneously with coronary sinus blood flow (CSBF) in 8 normal subjects and 11 patients with coronary artery disease at rest and during pacing stress. Mean values for CSBF and myocardial oxygen consumptions (MVO2) for the two groups were similar at rest and during pacing, although mean CSBF and MVO2 increased significantly in both groups in the paced as compared to the rest state.
INTRODUCTION
Transaminase reactions which catalyze the coniversion of pyruvate to alanine and a-ketoglutarate to glutamic acid are recognized as major metabolic branch points linking amino acid and carbohydrate metabolism (1, 2) . Alanine, glutamine, and glutamic acid are the only amino acids either taken up (glutamate) or released (alanine and glutamine) by human skeletal muscle (3) (4) (5) and thus appear to possess unique metabolic roles in normal oxygenated striated muscle. Pyruvate has been identified as the probable source of the three carbon fragment from which alanine is produced in human skeletal muscle, and glutamic acid has been postulated as the source of aminio nitrogen for the transamination reaction (6) (7) (8) (9) .
Evidence suggesting a central metabolic function for alanine and glutamic acid in oxygen-deprived tissue comes from studies which demonstrate alaniine accumulation (7, (10) (11) (12) (13) (14) and glutamate depletion (10, (13) (14) (15) during periods of anaerobic metabolism in mammalian tissue.
These observations, suggesting the hypothesis that chronic or repetitive bouts of myocardial ischemia may induce alterations in myocardial amino acid metabolism, prompted the present investigation. In this study, amino acid flux across the normal and is- Mean values for arteriovenous lactate differences were positive, indicating lactate extraction at rest and during pacing for the normal patients. Mean lactate values for the coronary group indicated extraction at rest (+0.08+0.04 nmol/ml) and production with pacing (-0.01+0.04 nmol/ml), although this pattern was not uniform within the group.
Transmyocardial amino acid arteriovenous differences. Mean transmyocardial arteriovenous differences for the basic, acidic, and neutral amino acids in the normal and coronary artery disease groups at rest and during pacing are tabulated in Table III Individual and mean±SEM values for transmyocardial arteriovenous alanine and glutamic acid differences and net transmyocardial alanine and glutamic acid flux in the rested (R) and paced (P) state for normal (nos. [1] [2] [3] [4] [5] [6] [7] [8] and coronary disease patients (nos. 9-19) are tabulated. Alanine release, arteriovenous difference, was significantly greater in the coronary group as compared to normals in both the rested (P < 0.001) and paced (P < 0.05) state. Net alanine release, flux, was significantly greater in the coronary group in the rested (P < 0.01) and paced (P < 0.05) state. Glutamic acid uptake, arteriovenous difference, was significantly greater in the coronary group in both the rested (P < 0.001) and paced (P < 0.05) state. Net glutamic acid uptake, flux, was significantly greater in the coronary group in the rested (P < 0.05) and paced (P < 0.02) state.
pacing value (4.3±11.8 nmol/ml) was not statistically different from zero.
In contrast, glutamate uptake was noted consistently in all coronary patients at rest and reversed to a negative value in only one patient during pacing.
Arteriovenous glutamate values decreased significantly during pacing from 59.0+8.9 to 35.3±6.3 nmol/ml in this group (P < 0.01). Calculation of net glutamate flux yielded comparative data similar to that obtained with arteriovenous differences with one notable exception. The net flux of glutamate in the coronary group, although lower during pacing (4,680+1,030 vs. 3,530+720 nmol/min), was not statistically different in the rest and paced states, in contrast to the comparison obtained between these two states with arteriovenous differences.
Significantly greater glutamate uptake was noted in the coronary disease group as compared to the normal group both at rest and during pacing when calculated as either arteriovenous difference or net flux (Table  IV) . Although arteriovenous differences decreased significantly with pacing in both groups and the net flux of glutamate was significantly lower in the normal Myocardial Amino Acid Metabolism paced as compared to the normal rest state, net flux did not decrease significantly during pacing in the coronary group.
DISCUSSION
Amino acid metabolism in the human heart has not been adequately studied despite the recognized relation between carbohydrate and amino acid metabolism (1, 2) and the importance of anaerobic carbohydrate metabolism as a potential energy source in the ischemic heart (22). Carlsten et al. reported that other than for the release of alanine, there is no net uptake or release of amino acids by the human heart (23) . Amino acid metabolism in human skeletal muscle is well characterized. In both forearm (9) and leg muscle (7), the release of alanine and glutamine and uptake of glutamate are found. The magnitude of the alanine efflux from skeletal muscle cannot be accounted for by the alanine content of skeletal muscle protein. Accordingly, it was first postulated and subsequently demonstrated that alanine is synthesized de novo in skeletal muscle by the transamination of pyruvate (24) .
The purpose of the present investigation was twofold: (a) to determine whether the pattern of transmyocardial amino acid differences resemble those of skeletal muscle, and (b) to test the hypothesis that cardiac amino acid metabolism as defined by arteriovenous difference studies might be altered in chronic ischemic heart disease. Our results indicate that while the pattern of amino acid metabolism in the normal and ischemic human heart is generally similar to that reported for skeletal muscle, differences can be found between normal and coronary disease groups which allow identification of the ischemic heart.
Alanine release from the normal myocardium occurred only during pacing stress and not at rest, whereas the diseased heart released alanine in both states in quantities sufficiently large to statistically differentiate the two groups. The degree of variation in alanine arteriovenous difference within each group was, however, so wide as to preclude the use of this index as a marker for coronary disease in a given individual, although coronary disease seems excluded if myocardial alanine uptake is found.
The pattern of glutamate arteriovenous differences in the diseased and normal heart at rest were qualitatively similar to that of skeletal muscle, i.e., significant uptake of glutamate occurred although uptake in the coronary group was greater than in the normal group to a degree that statistically differentiated the two groups. With pacing, the arteriovenous differences in the normal group decreased to zero, whereas glutamate uptake persisted in the coronary group despite a significant decrease in the arteriovenous difference.
Since arteriovenous difference studies do not provide direct measurements of intracellular tissue levels of specific metabolites, and both alaniine aind glutamate are known to participate in multiple biochemical reactions (1) , any explanations for the observed differences in metabolism of these amino acids in the heart of normal and coronary patients mllust remain speculative. In autolyzing rabbit heart, early increases in tissue lactate concentration are accompanied by a parallel increase in alanine and decrease in glutamate concentrations (10) . Similar data has been reported for anoxic rat liver (14) , whereas an increase in alanine but no decrease in glutamate was reportedl for ischemic rat liver (11) . In both the rabbit lheart and rat liver, changes in alanine and glutamate concentration induced by oxygen deprivation were blunted by pretreatment of the experimental animnals with L-cycloserine, a specific inhibitor of alaninie transaminase, indicating that alanine productioni is related to alanine transaminase activity.
It is therefore suggested that in the presence of higlh concentrations of tissue lactate, as occurs with oxygen deprivation, pyruvate conversion to lactate is rietarded due to the mass action effect of lactate accumulation with subsequent augmentation of glutamate-pyruvate transamination. This might result in a net reduction in the concentration of three carbon carbohydrate fragments accumulating in the foi-nn of lactate from glycolysis, although the amount of' alanine release found cannot account stoichiometrically for the amount of lactate generated during pacinig ischemia (Tables II and IV) . Biochemical evi(lenice suggesting the possibility of this reaction scheme comes from studies of oxygen deprived anid (or) working cardiac and skeletal muscle preparationis wherein increases in either pyruvate tissue conitent or venous efflux were noted (25) (26) (27) (28) (29) and the observation that the K,,, of alanine transaminase for pyrilvate decreases with acidosis (30) . The enhanced uptake of glutamate anid release of alanine noted in the coronary disease group is thus suggestive ofa metabolic adaptation ofthe myocardium to chronic ischemia. The fact that the differences in glutamate and alanine metabolism were present at rest and not just during an acutely induced ischemic state (pacing) supports this hypothesis. Similarly, the observation that glutamate uptake (net flux) decreased with pacing in the normals but was unchanged during pacing in the coronary disease group suggests an alteration of myocardial amino acid metabolism in response to chronic ischemia.
If indeed an adaptation of myocardial metabolism to chronic repetitive ischemia has been demonstrated, previous calculations of the capacity of glycolytic metabolism to generate high energy phosphate in ischemic myocardium based on studies of glycolysis in normal cardiac tissue may be in error (33) . Con- sideration of the possibility that myocardial metabolism in chronic coronary artery disease becomes more efficient in the glycolytic production of high energy phosphate due to adaptive biochemical changes seems warranted.
